Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.
Saved in:
| Title: | Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study. |
|---|---|
| Authors: | Yimer H; Texas Oncology-Tyler/US Oncology Research, Tyler, TX, USA., Melear J; US Oncology Research, Texas Oncology - Austin Midtown, Austin, TX, USA., Faber E; Oncology Hematology Care, Cincinnati, OH, USA., Bensinger WI; Myeloma & Transplant Program, Swedish Cancer Institute, Seattle, WA, USA., Burke JM; US Oncology Research, Rocky Mountain Cancer Centers, Aurora, CO, USA., Narang M; US Oncology Research, Maryland Oncology Hematology, P.A., Columbia, MD, USA., Stevens D; Norton Cancer Institute, Louisville, KY, USA., Gunawardena S; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Lutska Y; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Qi K; Janssen Research & Development, LLC, Titusville, NJ, USA., Ukropec J; Janssen Global Medical Affairs, Horsham, PA, USA., Qi M; Janssen Research & Development, LLC, Spring House, PA, USA., Lin TS; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Rifkin RM; US Oncology Research, Rocky Mountain Cancer Centers, Denver, CO, USA. |
| Source: | British journal of haematology [Br J Haematol] 2019 May; Vol. 185 (3), pp. 492-502. Date of Electronic Publication: 2019 Mar 03. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
